CLOV

SEC source: 0001999086-26-000007 · wk-form4_1773779451.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,200,061

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001839066-26-000007 · wk-form4_1773779577.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,722,568

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 15, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001839066-26-000007 · wk-form4_1773779577.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,728,755

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2026, of the final 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022.

SEC source: 0001971702-26-000003 · wk-form4_1773779231.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 925,611

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on March 14, 2026, of the final 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022.

SEC source: 0001938197-26-000004 · wk-form4_1772745373.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,998,584

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.16 to $2.18, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.

SEC source: 0001999086-26-000005 · wk-form4_1771452005.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,204,589

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on February 14, 2026, of the final 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022.

SEC source: 0001838733-26-000007 · wk-form4_1770760598.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,423,021

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on February 8, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001651691-26-000003 · wk-form4_1770068109.xml · nonDerivative · entry 1

Kuipers Peter J. · CIK 0001651691 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,758,353

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 29, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on April 29, 2024. The remaining RSUs vest in equal quarterly installments, with a final vesting date on April 29, 2028, in each case subject to the continued service of the Reporting Person on such vesting date.

SEC source: 0001801170-26-000024 · wk-form4_1768948713.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,737,700

F2 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.47 to $2.63, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001801170-26-000022 · wk-form4_1768948438.xml · nonDerivative · entry 2

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,173,584

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on January 18, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 18, 2022, and timely reported on a Form 4 filed on July 19, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on July 18, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-26-000028 · wk-form4_1768955327.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,508,725

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-26-000026 · wk-form4_1768950312.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,210,679

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-26-000025 · wk-form4_1768949161.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,025,806

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-26-000022 · wk-form4_1768948438.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,210,507

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-26-000024 · wk-form4_1768948713.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,742,297

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001839066-26-000004 · wk-form4_1767823793.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,757,029

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.61, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001801170-26-000013 · wk-form4_1767992888.xml · derivative · entry 5

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,591,093

Underlying: Class A Common Stock · 1,655,949 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · derivative.exercise_price: On January 7, 2026, the final 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,686,750 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,655,949 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.exercise_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.expiration_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

SEC source: 0001801170-26-000013 · wk-form4_1767992888.xml · derivative · entry 4

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,247,042

Underlying: Class A Common Stock · 3,342,699 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · derivative.exercise_price: On January 7, 2026, the final 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,686,750 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,655,949 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.exercise_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F1 · derivative.expiration_date: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

SEC source: 0001801170-26-000013 · wk-form4_1767992888.xml · derivative · entry 3

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Class B Common Stock · 3,342,699 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vested in equal installments on the first five anniversaries of January 7, 2021.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F3 · derivative.exercise_date: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vested in equal installments on the first five anniversaries of January 7, 2021.

F3 · derivative.expiration_date: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vested in equal installments on the first five anniversaries of January 7, 2021.

F3 · derivative.underlying: Each RSU represents a contingent right to receive one share of the Issuer's Class B Common Stock upon settlement for no consideration. The RSU award vested in equal installments on the first five anniversaries of January 7, 2021.

SEC source: 0001801170-26-000013 · wk-form4_1767992888.xml · nonDerivative · entry 2

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,856,247

F1 · security: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · shares: On January 7, 2026, the final 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,686,750 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,655,949 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

SEC source: 0001801170-26-000013 · wk-form4_1767992888.xml · nonDerivative · entry 1

Garipalli Vivek · CIK 0001839260 · Director · 10% owner

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,512,196

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · security: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

F2 · shares: On January 7, 2026, the final 20% of the original number of restricted stock units ("RSUs") in respect of a Class B Common Stock granted to the Reported Person on January 7, 2021 vested, with 1,686,750 shares of the Issuer's Class B Common Stock being delivered to the Reporting Person and 1,655,949 shares of the Issuer's Class B Common Stock automatically converting into an equal number of shares of the Issuer's Class A Common Stock and being withheld by the Issuer to cover the Reporting Person's tax obligations in connection with the vesting event.

F1 · price: The Issuer's Class B Common Stock is convertible into shares of the Issuer's Class A Common Stock on a one-to-one basis at the option of the holders of the Issuer's Class B Common Stock at any time upon written notice to the Issuer, and automatically in the event of certain transfers, including, but not limited to, a transfer of shares to the Issuer.

SEC source: 0001801170-26-000006 · wk-form4_1767906258.xml · nonDerivative · entry 1

Tran Thomas L · CIK 0001403759 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 180,029

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date.

SEC source: 0001801170-26-000007 · wk-form4_1767906326.xml · nonDerivative · entry 1

Robinson William G Jr · CIK 0001604046 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 597,987

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date.

SEC source: 0001801170-26-000010 · wk-form4_1767907231.xml · nonDerivative · entry 1

Kouzoukas Demetrios L. · CIK 0001856511 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 605,980

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date.

SEC source: 0001801170-26-000009 · wk-form4_1767906672.xml · nonDerivative · entry 1

Edwards Carladenise Armbrister · CIK 0001937412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 352,592

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date.

SEC source: 0001801170-26-000008 · wk-form4_1767906401.xml · nonDerivative · entry 1

Loengard Anna U · CIK 0001952723 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 527,456

F1 · shares: Represents shares of Class A Common Stock underlying an award of time-based restricted stock units (RSUs). The RSUs will vest in full on the first anniversary of January 6, 2026, subject to the Reporting Person's continued service as a director through such vesting date.

SEC source: 0001839066-26-000002 · wk-form4_1767647372.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,759,131

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on January 3, 2026, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001838733-26-000003 · wk-form4_1767655651.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,569,489

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on January 1, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001839066-25-000029 · wk-form4_1766102986.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,767,240

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.58 to $2.64, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001839066-25-000027 · wk-form4_1765933145.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,772,153

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 16, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001999086-25-000017 · wk-form4_1765919350.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,222,365

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 15, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on September 15, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on September 15, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001839066-25-000027 · wk-form4_1765933145.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,780,844

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001971702-25-000011 · wk-form4_1765920033.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,051,674

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on December 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on March 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on March 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001999086-25-000015 · wk-form4_1763500103.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,228,769

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 14, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on February 14, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on February 14, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001838733-25-000011 · wk-form4_1762981363.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,837,447

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on November 8, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001839066-25-000025 · wk-form4_1762379210.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,793,411

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.49 to $3.67, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001938197-25-000017 · wk-form4_1762299020.xml · nonDerivative · entry 2

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,228,583

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 31, 2025, of the final 12.5% of RSUs granted to the Reporting Person on October 31, 2023.

SEC source: 0001938197-25-000017 · wk-form4_1762299020.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,253,664

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 50% of the number of earned performance-based restricted stock units (RSU), as described herein. Each RSU represented a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units vested on October 31, 2025.

SEC source: 0001999086-25-000011 · wk-form4_1762295424.xml · nonDerivative · entry 2

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,236,228

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 31, 2025, of the final 12.5% of RSUs granted to the Reporting Person on October 31, 2023.

SEC source: 0001999086-25-000011 · wk-form4_1762295424.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · General Counsel & Secretary

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,274,314

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 50% of the number of earned performance-based restricted stock units (RSU), as described herein. Each RSU represented a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units vested on October 31, 2025.

SEC source: 0001839066-25-000022 · wk-form4_1762294579.xml · nonDerivative · entry 2

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,823,796

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 31, 2025, of the final 12.5% of RSUs granted to the Reporting Person on October 31, 2023.

SEC source: 0001839066-25-000022 · wk-form4_1762294579.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,853,309

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 50% of the number of earned performance-based restricted stock units (RSU), as described herein. Each RSU represented a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units vested on October 31, 2025.

SEC source: 0001971702-25-000009 · wk-form4_1762292771.xml · nonDerivative · entry 2

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,150,085

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on October 31, 2025, of the final 12.5% of RSUs granted to the Reporting Person on October 31, 2025.

SEC source: 0001971702-25-000009 · wk-form4_1762292771.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,178,015

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting of the final 50% of the number of earned performance-based restricted stock units (RSU), as described herein. Each RSU represented a right to a share of Class A Common Stock, earned in connection with the determination of the level of performance achievement in satisfaction of vesting conditions underlying a performance-based restricted share unit grant awarded on October 31, 2023. One-half of the number of earned restricted stock units vested and were settled on September 13, 2024, and the remaining one-half of the restricted stock units vested on October 31, 2025.

SEC source: 0001651691-25-000008 · wk-form4_1761942100.xml · nonDerivative · entry 1

Kuipers Peter J. · CIK 0001651691 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,915,209

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 29, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on April 29, 2024. The remaining RSUs vest in equal quarterly installments, with a final vesting date on April 29, 2028, in each case subject to the continued service of the Reporting Person on such vesting date.

SEC source: 0001938197-25-000013 · wk-form4_1761077241.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,340,274

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on October 18, 2025, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 18, 2022, and timely reported on a Form 4 filed on July 19, 2022. The remaining RSUs have a final vesting date occurring on July 18, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001839066-25-000019 · wk-form4_1761077350.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,955,226

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.65 to $2.72, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

SEC source: 0001938197-25-000011 · wk-form4_1760735144.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Home Care

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,388,579

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 15, 2025, due to the vesting of 25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001838733-25-000008 · wk-form4_1760734185.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,922,982

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 15, 2025, due to the vesting of 25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001839066-25-000017 · wk-form4_1760733859.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,971,740

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on October 15, 2025, due to the vesting of 25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.